Features Partner Sites Information LinkXpress
Sign In

Expandable Arterial Stent Helps Treat Iliac Stenosis

By HospiMedica International staff writers
Posted on 03 Jun 2014
Print article
Image: The Visi-Pro balloon-expandable stent system (Photo courtesy of Covidien).
Image: The Visi-Pro balloon-expandable stent system (Photo courtesy of Covidien).
A balloon-expandable stent system helps patients regain blood flow by treating lesions of the common and external iliac arteries.

The Visi-Pro balloon-expandable stent system is intended to improve and maintain artery luminal diameter in occlusions or lesions at high risk for abrupt closure following percutaneous transluminal angioplasty (PTA), or in lesions believed to be at high risk of stenosis following PTA in the common and external iliac, subbclavian, and renal arteries. The stent is also indicated for use as a palliative treatment of malignant neoplasms in the biliary tree.

The Visi-Pro is made from a 316L stainless steel tube with a diameter of 0.9 mm cut into an open lattice design; tantalum radiopaque markers are placed at the proximal and distal ends of the stent for guided placement. For delivery, the stent is mounted onto a tightly-folded balloon catheter, and then expanded and deployed by inflating the balloon. Other features include solid radial strength, flexibility, superior trackability, and a unique 5-fold balloon wrap that improves retraction.

In a prospective, multicenter, nonrandomized study that enrolled 75 patients at 17 centers in the United States and Europe, The Visi-Pro met its primary nine month endpoint, with a major adverse event rate of just 4%. Additionally, the technology achieved 100% device success, with primary patency and freedom from clinically-driven target lesion revascularization at nine months at 95.8%. The Visi-Pro is a product of Covidien (Dublin, Ireland), and has received the European Community CE marking of approval.

“The nine month results were positive, demonstrating the effectiveness of the technology in treating patients with iliac disease, regardless of gender, lesion location, or severity,” said lead author John Rundback, MD, of the Holy Name Medical Center (Teaneck, NJ, USA). “A unique benefit of the Visi-Pro stent is its excellent visibility during deployment, which optimizes precise positioning and minimizes the risk of geographic miss that is inherent to iliac stent procedures.”

Related Links:

Holy Name Medical

Print article


Critical Care

view channel

New Program Reduces COPD Hospital Readmissions

A treatment plan designed to help hospitals reduce chronic obstructive pulmonary disorder (COPD) related readmissions and costs also improves patient outcomes and quality of life. The COPD Seamless Treatment and Exacerbation Prevention (STEP) Plan, a partnership between Nonin Medical (Minneapolis, MN, USA) and Tri-anim... Read more

Women's Health

view channel

Droplet PCR System Identifies Fetal Genetic Data

A new study describes a simple, accurate, and low risk blood test that can detect fetal blood group, sex, and genetic conditions from a maternal blood sample. Developed by researchers at Plymouth University (United Kingdom), the new noninvasive fetal Rh blood group and D antigen (RhD) genotyping test can help prevent... Read more

Health IT

view channel
Image: Amblyz occlusion glasses (Photo courtesy of Xpand).

Electronic Glasses Effective in Amblyopia Treatment

A new study shows that programmable digital glasses for treating amblyopia (lazy eye) work as well as eye patching. Researchers at Indiana University (Bloomington, IN, USA) conducted a randomized clinical... Read more


view channel
Image: The BCH/Fractured FX ETV model (Photo courtesy of Boston Children\'s Hospital).

Boston Children's Hospital Partners with Fractured FX

Boston Children’s Hospital (BCH; MA, USA) has launched a collaboration with special effects company Fractured FX (Monrovia, CA, USA) to develop ultra-realistic models of patients' anatomy for surgical... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.